Anagin
Anagin is developing therapies that target mechanisms which result in neuropsychiatric diseases through abnormal neuroplasticity, inflammation, excitotoxicity and neurodegeneration.
Company Operating Status
Active
Country
Crunchbase URL
DUNS Number
078746613
Investors
LinkedIn URL
Location
Pitchbook URL
Official Website
Find more companies like Anagin
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.